12 results
DEF 14A
EQRX
EQRx, Inc.
12 Aug 22
Definitive proxy
4:05pm
diversity, equality and inclusion in its recruitment and talent development programs and efforts upholding a culture of equality and equity
POS AM
EQRX
EQRx, Inc.
23 Mar 22
Prospectus update (post-effective amendment)
6:30pm
or all targeted indications. Treatment-emergent side effects that are deemed to be drug-related could delay recruitment of clinical trial subjects … rights;
the recruitment or departure of key personnel;
the level of expenses related to any of our programs and product candidates or preclinical
10-K
2021 FY
EQRX
EQRx, Inc.
23 Mar 22
Annual report
4:43pm
-related could delay recruitment of clinical trial subjects or may cause subjects that enroll in our clinical trials to discontinue participation … or disputes concerning patent applications, issued patents or other proprietary rights;
the recruitment or departure of key personnel;
the level of expenses
424B3
EQRX
EQRx, Inc.
23 Dec 21
Prospectus supplement
5:24pm
recruitment of clinical trial subjects or may cause subjects that enroll in our clinical trials to discontinue participation in our clinical trials … or other proprietary rights;
the recruitment or departure of key personnel;
the level of expenses related to any of our programs and product
424B3
tyos8mwjhj1ll6 0nqql
1 Dec 21
Prospectus supplement
4:43pm
S-4/A
1imtffww
1 Oct 21
Registration of securities issued in business combination transactions (amended)
9:52pm
S-4
p42cosk8df8tl h9h
25 Aug 21
Registration of securities issued in business combination transactions
3:21pm
S-1
EX-99.3
bq28v0 n6q1b
25 Feb 21
IPO registration
12:00am
- Prev
- 1
- Next